Publications

Chari A, Voorhees PM, Thertulien R. Redefining second-line treatment strategy, sequencing, and real-world implementation in relapsed/refractory multiple myeloma: insights from the 31st Annual Congress of the European Hematology Association. Clinical advances in hematology & oncology : H&O. 2026. PMID: 42748346

Chari A. Relapsed/refractory multiple myeloma: disease overview and treatment landscape. Clinical advances in hematology & oncology : H&O. 2026. PMID: 42748347

Elia MV, Friesner ID, Kwon D, Ni L, Sinha S, Ishiyama Y, Zack T, Bridge M, Fong L, Hong JC. Large Language Models and Adverse Event Detection Within Immunotherapy Clinical Trials. JAMA network open. 2026. PMID: 42690663

Draper LM, Komanduri KV. Lifileucel Delivers in Practice-Can Attrition be Reduced? Transplantation and cellular therapy. 2026. PMID: 42697689

Hawes MR, Alway J, Chakravarty D, Xia F, Kushel M, Max W, Vijayaraghavan M. Smoke-Free Home Intervention in Permanent Supportive Housing: A Cluster Randomized Clinical Trial. JAMA network open. 2026. PMID: 42714909

Banik I, Basu S, Wang M, Escobar AJ, Steri V, Camara Serrano JA, Phojanakong P, Pacheco NC, Tsai KK, Alvarez EA, Daud A, El-Sayed IH, Samarkina A, Xu J, Aquino JD, Xiao M, Herlyn M, Yeh I. A Technique for the Generation of Mucosal and Acral Melanoma Cell Lines. Pigment cell & melanoma research. 2026. PMID: 42698217

Pan D, Kumar A, Lipof JJ, Chung A, Wolf JL, Martin TG, Arora S, Sayre PH, Chari A. GPRC5D-targeting bispecific and trispecific antibodies in multiple myeloma: Current evidence and emerging strategies. Cancer. 2026. PMID: 42675812

Chari A, Voorhees PM, Thertulien R. Practical approach to second-line treatment strategy, sequencing, and real-world implementation in relapsed/refractory multiple myeloma: Q&A. Clinical advances in hematology & oncology : H&O. 2026. PMID: 42748350

Neupane A, Budhu A, Mehrabadi FR, He A, Goyal L, Kelley RK, Greten TF, Wang XW. Plasma cell-CD8+ T cell co-enrichment distinguishes immunotherapy-responsive hepatocellular carcinoma subtypes. eGastroenterology. 2026. PMID: 42688584

Chari A, Touzeau C, Berdeja JG, Oriol A, van de Donk NW, Rodríguez-Otero P, Morillo D, Martinez-Chamorro C, Mateos MV, Costa LJ, Caers J, Rasche L, Krishnan A, Ye JC, Karlin L, Lipe B, Masterton T, Tolbert J, Renaud T, Kane C, Heuck C, Moreau P. Talquetamab for people living with relapsed/ refractory multiple myeloma: plain language summary of the MonumenTAL-1 study. Future oncology (London, England). 2026. PMID: 42669079

Ko AH. RASolute 302: Lessons Learned and the Road Ahead in Pancreatic Cancer. The oncologist. 2026. PMID: 42664076

Chiang AY, Vijayaraghavan M. Intersectional Disparities in Adult Cigarette Smoking, E-Cigarette Use, and Cannabis Use Among Sexual and Gender and Racial and Ethnic Minorities in California. American journal of public health. 2026. PMID: 42659581

Li Z, Ai W, Zhang J, Bacha AUR, Chen W, Wang Y, Li Y, Cao Y, Li W, Yang L, Ma J. Iron-Doped Carbon Nanotubes Facilitate ZnO Interfacial Charge Accumulation for Selective Singlet Oxygen Generation in Piezo-Photocatalytic Microplastics Upcycling. Environmental science & technology. 2026. PMID: 42674644

Xu H, Kamei C, Gökbuget D, Du J, Barrero M, Wang L, Iwamoto Y, Soriano JM, Godding K, Wang B, Kwek SS, Nistor GI, Keirstead HS, Fong L, Kaneko S, Gaensler KML, Blelloch R. Engineered human iPSC-derived dendritic cells dressed with tumor MHC complexes as a cancer vaccine. Cell stem cell. 2026. PMID: 42641609

Carlo MI, Schroeder A, Liu J, Ravichandran V, Mehta N, Kemel Y, Zong G, Liu Y, Latham A, Shah N, Feldman D, Voss MH, Kotecha R, Stadler ZK, Robson ME, Mehine M, Bandlamudi C, Berger MF, Chen Y, Mandelker D, Bolton K, Mukherjee S, Offit K, Motzer R. Expanding the phenotype of hereditary renal cell carcinoma syndromes: Implications for surveillance and management. Journal of the National Cancer Institute. 2026. PMID: 42635527

Facon T, Kumar SK, Orlowski RZ, Bahlis N, Moreau P, Goldschmidt H, Basu S, Hulin C, Zweegman S, Weisel K, Perrot A, Jacquet C, Raje N, Manier S, Chari A, Hansson M, Mohty M, Delforge M, Plesner T, Cook G, Leleu X, Quach H, Venner CP, Tiab M, Macro M, Frenzel L, Wang G, Pei H, Bolyard K, Carson R, Borgsten F, Usmani SZ. Daratumumab, lenalidomide, and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma: MAIA final survival analysis. Leukemia. 2026. PMID: 42637879

Rugo HS, Tolaney SM, Chan N, Borges G, Yerushalmi R, Sharifi MN, McHayleh W, Beck T, Vidula N, Hamilton E, Rinn KJ, O'Shaughnessy J, Curigliano G, Cortés J, Garcia-Fructuoso I, Aftimos P, Bermejo de Las Heras B, Tolosa P, Yuan Y, Valero V, Lipsyc-Sharf M, Muñoz Romero P, Koraichi Auriol F, Paoli A, Crozier JA, Wasserman T, Kaklamani V. Elacestrant in Combination with Everolimus for Estrogen Receptor-Positive, HER2-Negative Previously Treated Advanced Breast Cancer: Results from ELEVATE. Clinical cancer research : an official journal of the American Association for Cancer Research. 2026. PMID: 42635598

Yang X, Dumke H, Kambhampati Thiruvengadam S, Argao C, Schroers-Martin JG, Lanka S, Sawalha Y, Alharthy H, Ahmed S, Okcu I, Nowakowski GS, Doukas PG, Karmali R, Shanmugasundaram K, Colton M, Spinner MA, Marron Rodriguez S, DuVall AS, Lakin BG, D'Angelo CR, Pizzuti VJ, Kamdar M, Adewale O, Rhodes JM, Tiger YKR, Baron K, Bock AM, Geer MJ, Karimi YH. Second Line CD19 CAR-T vs Platinum Salvage and Autologous Stem Cell Transplant for Primary Mediastinal B-Cell Lymphoma. Blood advances. 2026. PMID: 42623675

Kretschmer LS, Mitchell DC, Liu J, Leak L, Turnham RE, Wang L, Wang Z, He C, Ding L, Adler M, Kellett T, Keith A, Hwang YC, Chan GKL, Gottschalk RLG, Li W, Chan LM, Ramamoorthi R, Lively S, Drakas RA, Ramani V, Qing T, Verba KA, Bivona T, Ostrem JML, Beresis RT, Gordan JD. Small-molecule activation of the tumor suppressor kinase LKB1 via the pseudokinase STRAD. Cell chemical biology. 2026. PMID: 42612636

Lavery JA, Brown S, Nichols C, Jolissaint JS, Deng Y, Lee J, Shah NJ, Bahadur N, Niederhausern A, Philip J, Kehl KL, Schrag D, Panageas KS. Rule-Based Identification of a Reliable Real-World Cancer Recurrence Endpoint. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2026. PMID: 42606327